Showing results (1741-1750 of 1,998) with videos related to

Sort By:
Pageof 200
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 20, 2019
Why public health matters today and tomorrow: the role of applied public health researchLindsay McLaren, Paula Braitstein, David Buckeridge, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrininU Gubler, J J Monahan, P T Lomedico, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|September 3, 2020
Correction to: Why public health matters today and tomorrow: the role of applied public health researchLindsay McLaren, Paula Braitstein, David Buckeridge, et al.
Nuclear Medicine and Biology|June 27, 2007
Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3Huma Mohsin, Jonathan Fitzsimmons, Tiffani Shelton, et al.
Neurology|March 13, 2013
Gustation assessment using the NIH ToolboxSusan E Coldwell, Julie A Mennella, Valerie B Duffy, et al.
Plos One|October 3, 2023
Primary complex motor stereotypies are associated with de novo damaging DNA coding mutations that identify KDM5B as a risk geneThomas V Fernandez, Zsanett P Williams, Tina Kline, et al.
Vaccine|June 23, 2026
Factors associated with COVID-19 vaccine acceptance among refugee women at Dzaleka refugee camp in MalawiKaboni Whitney Gondwe, Mary O Hearst, Hellen R Mbutuka, et al.
BMC Medical Genomics|October 18, 2008
Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMTGuiqing Cai, Lisa Edelmann, Juliet E Goldsmith, et al.
Circulation. Cardiovascular Genetics|January 29, 2015
SH2B3 Is a Genetic Determinant of Cardiac Inflammation and FibrosisMichael J Flister, Matthew J Hoffman, Angela Lemke, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2014
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancerNestor F Esnaola, Uzair B Chaudhary, Paul O'Brien, et al.
Pageof 200